Timo Erkinjuntti

32.4k total citations · 5 hit papers
170 papers, 16.0k citations indexed

About

Timo Erkinjuntti is a scholar working on Psychiatry and Mental health, Neurology and Epidemiology. According to data from OpenAlex, Timo Erkinjuntti has authored 170 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Psychiatry and Mental health, 48 papers in Neurology and 45 papers in Epidemiology. Recurrent topics in Timo Erkinjuntti's work include Dementia and Cognitive Impairment Research (67 papers), Acute Ischemic Stroke Management (38 papers) and Cerebrovascular and Carotid Artery Diseases (34 papers). Timo Erkinjuntti is often cited by papers focused on Dementia and Cognitive Impairment Research (67 papers), Acute Ischemic Stroke Management (38 papers) and Cerebrovascular and Carotid Artery Diseases (34 papers). Timo Erkinjuntti collaborates with scholars based in Finland, Italy and Sweden. Timo Erkinjuntti's co-authors include Leonardo Pantoni, Philip Scheltens, Raimo Sulkava, Franz Fazekas, Lars‐Olof Wahlund, Markku Kaste, Tarja Pohjasvaara, Frederik Barkhof, Anders Wallin and Anders Wallin and has published in prestigious journals such as New England Journal of Medicine, NeuroImage and Brain.

In The Last Decade

Timo Erkinjuntti

167 papers receiving 15.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT

2001 1.4k citations Lars‐Olof Wahlund, Frederik Barkhof et al. profile →
Subcortical ischaemic vascular dementia

2002 776 citations Gustavo C. Román, Timo Erkinjuntti et al. profile →
Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

1998 571 citations Raimo Sulkava, Timo Erkinjuntti et al. profile →
Vascular Cognitive Impairment

2014 438 citations John T. O’Brien, Timo Erkinjuntti et al. profile →
Post‐stroke cognitive impairment is common even after successful clinical recovery

2015 316 citations Hanna Jokinen, Raija Ylikoski et al. European Journal of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timo Erkinjuntti Finland	68	6.1k	4.2k	3.6k	3.4k	3.2k	170	16.0k
Leonardo Pantoni Italy	70	6.3k 1.0×	6.7k 1.6×	6.5k 1.8×	5.1k 1.5×	5.3k 1.7×	305	21.3k
Didier Leys France	69	4.7k 0.8×	3.5k 0.8×	7.1k 2.0×	7.1k 2.1×	5.2k 1.6×	437	20.2k
Raj N. Kalaria United Kingdom	77	4.7k 0.8×	7.6k 1.8×	4.7k 1.3×	2.6k 0.8×	2.3k 0.7×	277	19.7k
Florence Pasquier France	65	8.8k 1.4×	3.7k 0.9×	3.6k 1.0×	2.2k 0.6×	1.6k 0.5×	362	19.1k
John C. van Swieten Netherlands	64	4.9k 0.8×	4.2k 1.0×	10.0k 2.8×	4.5k 1.3×	2.6k 0.8×	268	23.7k
Hans‐Christoph Diener Germany	77	6.0k 1.0×	3.0k 0.7×	3.4k 1.0×	4.0k 1.2×	2.3k 0.7×	329	19.9k
Etsuro Mori Japan	69	3.9k 0.6×	2.0k 0.5×	5.4k 1.5×	3.0k 0.9×	1.8k 0.6×	378	16.0k
Vincent Mok Hong Kong	56	3.0k 0.5×	2.4k 0.6×	4.1k 1.1×	3.6k 1.0×	1.9k 0.6×	436	12.8k
Charles DeCarli United States	90	9.5k 1.6×	4.0k 1.0×	3.1k 0.9×	2.8k 0.8×	3.0k 1.0×	447	23.9k
Rebecca F. Gottesman United States	72	4.3k 0.7×	2.1k 0.5×	2.2k 0.6×	3.1k 0.9×	2.7k 0.8×	508	17.6k

Countries citing papers authored by Timo Erkinjuntti

Since Specialization

Citations

This map shows the geographic impact of Timo Erkinjuntti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Erkinjuntti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Erkinjuntti more than expected).

Fields of papers citing papers by Timo Erkinjuntti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Erkinjuntti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Erkinjuntti. The network helps show where Timo Erkinjuntti may publish in the future.

Co-authorship network of co-authors of Timo Erkinjuntti

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Erkinjuntti. A scholar is included among the top collaborators of Timo Erkinjuntti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Erkinjuntti. Timo Erkinjuntti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Poggesi, Anna, Alida A. Gouw, Wiesje M. van der Flier, et al.. (2014). Neurological abnormalities predict disability: the LADIS (Leukoaraiosis And DISability) study. Journal of Neurology. 261(6). 1160–1169. 14 indexed citations

2.

Verdelho, Ana, S. Madureira, Carla Moleiro, et al.. (2010). White matter changes and diabetes predict cognitive decline in the elderly. Neurology. 75(2). 160–167. 148 indexed citations

3.

Inzitari, Domenico, Giovanni Pracucci, Anna Poggesi, et al.. (2009). Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ. 339(jul06 1). b2477–b2477. 305 indexed citations

4.

Poggesi, Anna, Giovanni Pracucci, Hugues Chabriat, et al.. (2008). Urinary Complaints in Nondisabled Elderly People with Age‐Related White Matter Changes: The Leukoaraiosis And DISability (LADIS) Study. Journal of the American Geriatrics Society. 56(9). 1638–1643. 67 indexed citations

5.

Gouw, Alida A., Wiesje M. van der Flier, Elisabeth C.W. van Straaten, et al.. (2006). Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. Journal of Neurology. 253(9). 1189–1196. 98 indexed citations

6.

Ryberg, Charlotte, Egill Rostrup, M.B. Stegmann, et al.. (2006). Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiology of Aging. 28(6). 955–963. 59 indexed citations

7.

Vataja, Risto, Tarja Pohjasvaara, Riitta Mäntylä, et al.. (2003). MRI correlates of executive dysfunction in patients with ischaemic stroke. European Journal of Neurology. 10(6). 625–631. 76 indexed citations

8.

Leppävuori, Antero, Risto Vataja, Tarja Pohjasvaara, et al.. (2003). Alcohol Misuse: A Risk Factor for Putaminal Damage by Ischemic Brain Infarct?. European Neurology. 50(2). 69–72. 2 indexed citations

9.

Erkinjuntti, Timo, et al.. (2002). RIVASTIGMINE IN PATIENTS WITH ALZHEIMER'S DISEASE AND CONCURRENT HYPERTENSION. International Journal of Clinical Practice. 56(10). 791–796. 29 indexed citations

10.

Erkinjuntti, Timo. (2001). Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD.. PubMed. 14–23. 24 indexed citations

11.

Erkinjuntti, Timo, Domenico Inzitari, Leonardo Pantoni, et al.. (2000). Research criteria for subcortical vascular dementia in clinical trials. PubMed. 59. 23–30. 464 indexed citations

12.

Erkinjuntti, Timo, John V. Bowler, Charles DeCarli, et al.. (1999). Imaging of Static Brain Lesions in Vascular Dementia: Implications for Clinical Trials. Alzheimer Disease & Associated Disorders. 13(Supplement 3). S81–S90. 45 indexed citations

13.

Pantoni, Leonardo, Didier Leys, Franz Fazekas, et al.. (1999). Role of White Matter Lesions in Cognitive Impairment of Vascular Origin. Alzheimer Disease & Associated Disorders. 13(Supplement 3). S49–S54. 27 indexed citations

14.

Pantoni, Leonardo, Didier Leys, Franz Fazekas, et al.. (1999). Role of White Matter Lesions in Cognitive Impairment of Vascular Origin. Alzheimer Disease & Associated Disorders. 13(Supplement). S49–54. 63 indexed citations

15.

Inzitari, Domenico, Timo Erkinjuntti, Anders Wallin, Teodoro del Ser, & Leonardo Pantoni. (1999). Is Subcortical Vascular Dementia a Clinical Entity for Clinical Drug Trials?. Alzheimer Disease & Associated Disorders. 13(Supplement 3). S66–S68. 1 indexed citations

16.

Erkinjuntti, Timo, Truls Østbye, Runa E. Steenhuis, & Vladimir Hachinski. (1997). The Effect of Different Diagnostic Criteria on the Prevalence of Dementia. New England Journal of Medicine. 337(23). 1667–1674. 337 indexed citations

17.

Valvanne, Jaakko, Reijo S. Tilvis, Kati Juva, & Timo Erkinjuntti. (1996). Major Depression in the Elderly: A Population Study in Helsinki. International Psychogeriatrics. 8(3). 437–443. 59 indexed citations

18.

Erkinjuntti, Timo, et al.. (1994). Moderate alcohol consumption and loss of cerebellar Prikinje cells. BMJ. 308(6945). 1663–1667. 80 indexed citations

19.

Sulkava, Raimo & Timo Erkinjuntti. (1988). Diuretics in the elderly. BMJ. 297(6641). 132.4–133. 3 indexed citations

20.

Elovaara, Irina, Ilkka Seppälä, J. Palo, Raimo Sulkava, & Timo Erkinjuntti. (1988). Oligoclonal immunoglobulin bands in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Acta Neurologica Scandinavica. 77(5). 397–401. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact